Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$25,980
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$26K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-09-10 EPIC PHARMA LLC 10% owner Grant or award · Series E Convertible Preferred Stock +250 $1,000.00 $250K 2,187.5
2012-09-10 EPIC INVESTMENTS, LLC 10% owner Grant or award · Series E Convertible Preferred Stock +250 $1,000.00 $250K 2,187.5
2012-06-29 NIGALAYE ASHOK G Chief Scientific Officer Grant or award · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 NARINE JEENARINE Director Grant or award · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 EPIC PHARMA LLC 10% owner Grant or award · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 EPIC INVESTMENTS, LLC 10% owner Grant or award · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 POTTI RAM Director Grant or award · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 NARINE JEENARINE Director Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 NARINE JEENARINE Director Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 POTTI RAM Director Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 NIGALAYE ASHOK G Chief Scientific Officer Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 EPIC PHARMA LLC 10% owner Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-29 EPIC INVESTMENTS, LLC 10% owner Purchase · Series E Convertible Preferred Stock +187.5 $1,000.00 $188K 1,937.5
2012-06-19 Ward Carter Julian Chief Financial Officer Grant or award · Options +150,000 150,000
2012-05-04 Ward Carter Julian Chief Financial Officer & Sec. Other acquisition +1,355,014 $0.04 $50K 1,870,747
2012-05-04 POTTI RAM Director Other disposition −9,214,097 $0.04 $340K 27,369,355
2012-05-04 NARINE JEENARINE Director Other disposition −9,214,097 $0.04 $340K 27,777,304
2012-05-04 NIGALAYE ASHOK G Chief Scientific Officer Other disposition −9,214,097 $0.04 $340K 27,777,304
2012-05-04 EPIC PHARMA LLC 10% owner Other disposition −9,214,097 $0.04 $340K 27,137,722
2012-05-04 EPIC INVESTMENTS, LLC 10% owner Other disposition −9,214,097 $0.04 $340K 27,137,722

Page 21 of 28 · 542 trades